Analysis of Patient Preferences in Lung Cancer - Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects.

Ellen M JanssenSydney M DyAlexa Simon MearaPeter J KneuertzCarolyn J PresleyJohn F P Bridges

Published in: Patient preference and adherence (2020)

Participants would trade PFS for changes in short-term side effects and long-term side effects, although preference heterogeneity existed. Lung cancer treatments that offer less PFS but also less severe side effects might be acceptable to some patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
case report
early onset
peritoneal dialysis
smoking cessation
drug induced